Back to search results

REACH Study: Geriatric Co-Management for Older Adults with GI Cancers

This study, called REACH, is looking at how involving a geriatrician (a doctor specializing in older adults' health) in the care of older adults with gastrointestinal (GI) cancers might improve their health. You could be eligible if you are 70 or older, have a GI cancer (like stomach, colon, or pancreatic cancer), and receive care at DF/BWCC. The study is testing a "Geriatric Co-Management" approach. Participants will complete a questionnaire to assess their fitness. If you are identified as "Pre-Frail" or "Frail," you might be randomized to meet with a geriatrician in addition to your usual care. The researchers want to see if this consultation can reduce unplanned emergency room visits or hospital stays. The study is currently recruiting for its Phase 2 intervention.

Study design
This is an interventional study with a planned enrollment of 257 participants. It involves a Phase 2 intervention where some participants will be randomized to receive geriatric co-management.
What's involved
Participants will complete an electronic fitness assessment questionnaire. Those identified as "Pre-Frail" or "Frail" may be randomized to meet with a study geriatrician.
Compensation
Not stated in the trial record.
Follow-up
The study will measure outcomes like unplanned ED visits and hospitalizations for one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04674267

Resilience and Equity in Aging, Cancer, and Health (REACH)

Recruiting
NAAges 70+InterventionalHealth services
Dana-Farber Cancer Institute
~257 participants
Updated 2026-03-18 on ClinicalTrials.gov
What's tested:Phase 2 Intervention - Geriatric Co-Management

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of electronic fitness assessment questionnaire (developed from Comprehensive Geriatric Assessment tool)
Measured over 1 year
+2 more outcomes measured

Conditions

Gastric Cancer
Colon Cancer
Esophageal Cancer
Rectal Cancer
Pancreatic Cancer
Gastrointestinal Cancer

Explore related trials

Ampullary CancerAnal CarcinomaBile Duct CarcinomaColon CarcinomaEsophageal CarcinomaGastric CarcinomaLiver CarcinomaMalignant Digestive System NeoplasmNeuroendocrine NeoplasmPancreatic CarcinomaRectal Carcinoma

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Nadine J McCleary, MD, MPH · PRINCIPAL_INVESTIGATOR · Dana-Farber Cancer Institute

Who to contact

Nadine J McCleary, MD, MPH
[email protected]
877-442-3324
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients who are age 70+ at time of initial consult at DF/BWCC
Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.
Continuing care at DF/BWCC beyond initial consult visit
English and Spanish-speaking

Exclusion

Patients less than age 70 at time of initial consultation appointment with DF/BWCC.
Patients who are not continuing care at DF/BWCC beyond first consult visit.
Not proficient in English or Spanish
Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.
Participants with psychiatric illness/social situations that would limit compliance with study requirements.

What this trial measures

  • Feasibility of electronic fitness assessment questionnaire (developed from Comprehensive Geriatric Assessment tool)1 year

    EFA questionnaire deployed to older adult patients age 70+ in the REACH study. Feasibility will be determined by the proportion of participants who consent to complete the electronic fitness assessment. The intervention will be considered feasible if 70% of participants consent to complete the fitness assessment.

  • Acceptability of electronic fitness assessment questionnaire1 year

    Acceptability of electronic fitness assessment questionnaire via the Patient Portal or internet-enabled device following second clinic visit among older adults diagnosed with gastrointestinal cancer seeking consultation at DF/BWCC for medical, radiation, or surgical oncology. Acceptability will be determined by the proportion of participants who fully complete the EFA. The intervention will be considered acceptable if 60% of enrolled participants fully complete the EFA within 14 days of enrollment.

  • Association of geriatric consultation with number of unplanned ED visits/hospitalizations among older adult participants1 year

    Association of geriatrician consult with number of ED visits/hospitalizations among older adults diagnosed with gastrointestinal cancer randomized to the geriatric consultation intervention. Randomization will be essential to evaluate the efficacy of geriatric consultation intervention in impacting unplanned ED visits and hospitalizations.